X4 Pharmaceuticals (XFOR) to Offer Common Stock

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) announced today that it has commenced an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and accompanying warrants to purchase shares of its common stock (or pre-funded warrants). In addition, X4 expects to grant the underwriters a 30-day option to purchase additional shares of its common stock and/or warrants to purchase shares of its common stock at the public offering price, less the underwriting discounts and commissions. All of the securities in the offering will be sold by X4. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Tango Therapeutics prices $600 million public offering at $30 per share
• PENN Entertainment (PENN) PT Raised to $25 at Stifel After Investor Meetings
• Kimco (KIM) PT Raised to $28 at Stifel